| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443631 | European Journal of Cancer | 2014 | 10 Pages |
Abstract
Cases with RM and DM mBCC may have different clinical courses and outcomes. Based on published reports, DM cases were younger at mBCC diagnosis, with shorter median survival than RM cases. This study provides a historical context for emerging mBCC treatments.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Margaret McCusker, Nicole Basset-Seguin, Reinhard Dummer, Karl Lewis, Dirk Schadendorf, Aleksandar Sekulic, Jeannie Hou, Lisa Wang, Huibin Yue, Axel Hauschild,